Results
10
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
10 companies
BlinkLab
Market Cap: AU$67.0m
Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.
BB1
AU$0.54
7D
0%
1Y
127.7%
PolyNovo
Market Cap: AU$1.1b
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.60
7D
15.2%
1Y
-38.9%
Advanced Health Intelligence
Market Cap: AU$22.6m
Operates as a mobile application and technology development company in Australia and internationally.
AHI
AU$0.092
7D
0%
1Y
15.0%
CurveBeam AI
Market Cap: AU$49.4m
Engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America and internationally.
CVB
AU$0.13
7D
-3.8%
1Y
-26.5%
Doctor Care Anywhere Group
Market Cap: AU$73.3m
Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.
DOC
AU$0.20
7D
11.1%
1Y
181.7%
Regis Healthcare
Market Cap: AU$2.7b
Engages in the provision of residential aged care services in Australia.
REG
AU$9.12
7D
14.0%
1Y
59.4%
Artrya
Market Cap: AU$276.5m
A medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.
AYA
AU$2.35
7D
10.3%
1Y
803.8%
Austco Healthcare
Market Cap: AU$133.4m
Engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America.
AHC
AU$0.36
7D
-3.9%
1Y
58.7%
Alcidion Group
Market Cap: AU$120.9m
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
ALC
AU$0.09
7D
1.1%
1Y
47.5%
CleanSpace Holdings
Market Cap: AU$58.7m
Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide.
CSX
AU$0.75
7D
-6.3%
1Y
59.6%